Clinical Drug Experience Knowledgebase

Criteria

Inclusion Criteria:

Adult males 18 years to 64 years of age;
Good general health (as evidenced by no chronic conditions, normal physical exam, vital signs within normal limits; laboratory evaluations within normal range)
Signed and dated written informed consent form; and
Willing to participate in all study activities and all requirements, including effective contraception (viz., a double-barrier method) during the 7-day study surveillance period.

Exclusion Criteria:

Hematology, serum chemistry (exclusive of electrolytes), and urinalysis laboratory test values >2 times upper limits of normal or anemia (hemoglobulin <11 g/dL), leukopenia (total white blood count <3,000/µL or total neutrophils <1,500/ µL) or thrombocytopenia (platelets <100,000/µL). Electrolytes and coagulation values exceeding normal ranges are to be excluded.
Body Mass Index (BMI) >35.
Calculated creatinine clearance (by the Cockroft and Gault Formula) <70 mL/min, based on age and gender.
Positive HIV-1 or HIV-2 serology.
Positive HCV serology and/or positive plasma HCV-RNA status.
Positive HBsAg or HBcAb status.
Solid or hematopoetic organ transplant recipient.
Active illness or recent illness within 30 days of the first dose of study drug.
History of any of the following: brain injury, neoplasm, chronic or migraine headaches, cancer, meningitis or hydrocephalus.
Usage of any prescribed, over-the-counter or illicit drug(s) within 30 days of study drug administration. Use of herbal remedies and/or supplements at the discretion of the Investigator.
Unwilling to practice effective contraception during the study period.
Participation in any clinical interventional trial within the previous 6 months.
Positive drug urine screen.